Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE1376.3026.3 (+1.95 %)
PREV CLOSE () 1350.00
OPEN PRICE () 1365.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 452167
TODAY'S LOW / HIGH ()1356.75 1414.40
52 WK LOW / HIGH ()1149 1414.4
NSE1375.7025.2 (+1.87 %)
PREV CLOSE() 1350.50
OPEN PRICE () 1388.40
BID PRICE (QTY) 1375.70 (252)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8857211
TODAY'S LOW / HIGH() 1355.80 1414.90
52 WK LOW / HIGH ()1148.4 1414.9
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office :

Address : 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone : 040 - 4900 2900

Website : www.drreddys.com

Registrar's Details : Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, New York
NEWS
20Jun Dr Reddys Laboratories informs about p
Dr Reddys Laboratories has informed that it enclosed copies of the newsp..
13Jun Dr. Reddy’s launches Bosutinib Tablets
Dr. Reddy’s Laboratories has launched Bosutinib Tablets 400mg, a generic..
16May Dr. Reddy’s Laboratories informs abou
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release,..
16May Dr. Reddy's Laboratories launches gene
Dr. Reddy's Laboratories has launched its generic Semaglutide Injection..
13May Dr. Reddy's Laboratories reports 86% p
Dr. Reddy's Laboratories has reported results for fourth quarter (Q4) an..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit-219432197
Gross Profit -3055 42513
Operating Profit 67356070
Net Sales 38220205328
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Kwality Pharma (BSE)
 2717.65 (11.83%)
M.Cap ( in Cr)
2819.89
Acutaas Chemicals (BSE)
 3548.30 (7.61%)
M.Cap ( in Cr)
29050.33
Ajanta Pharma (BSE)
 3377.90 (6.29%)
M.Cap ( in Cr)
42202.00
Torrent Pharma (BSE)
 4660.15 (3.14%)
M.Cap ( in Cr)
157720.65
Neuland Laboratories (BSE)
 18062.80 (0.70%)
M.Cap ( in Cr)
23174.37
Shareholding Pattern
PROMOTERS 26.63%
FI/BANKS/INSURANCE 14.7%
MUTUAL FUNDS/UTI 13.19%
NON-INSTITUTION 9.57%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76728.37-372.10 (-0.48%)
NIFTY23946.25-109.75 (-0.46%)
Dow Jones 51876.11-44.51 (-0.09%)
Nasdaq 25297.62-60.98 (-0.24%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI